DESCRIPTION OF BUSINESS - License and Distribution Agreements (Precision Autoimmune Therapeutics Co., Ltd) (Details) - Precision Autoimmune Therapeutics Co., Ltd ¥ in Millions |
1 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
May 31, 2022
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2025
CNY (¥)
|
Dec. 31, 2025
USD ($)
|
Apr. 30, 2025
CNY (¥)
|
May 31, 2022
CNY (¥)
installment
|
May 31, 2022
USD ($)
installment
|
|
| Description of Business and Basis of Presentation | |||||||
| Upfront payment | $ 10,000,000 | ||||||
| Number of installments for upfront payment | installment | 2 | 2 | |||||
| Aggregate consideration for equity investment | ¥ 56.8 | $ 8,100,000 | ¥ 20.0 | $ 3,000,000 | |||
| Sublicensing revenue from a related party | $ 5,000,000 | ||||||
| CASI China | |||||||
| Description of Business and Basis of Presentation | |||||||
| Aggregate consideration for equity investment | ¥ | ¥ 28.4 | ||||||